Syndax Pharmaceuticals, Inc.

NASDAQ:SNDX

Biotechnology

Healthcare
$9.13 +0.66%

+$0.13 today

Market cap
$821.96M
Beta
0.39
P/E (TTM)
-6.8
EPS (TTM)
-$2.81
52W Low $8.59High $25.59

Volume 3.30M

Average 1.70M

Balance Sheet

Inspect the capital base behind the business.

Assets

$529.71M

FY 2025 · Annual

-26.9% YoY

Liabilities

$465.08M

FY 2025 · Annual

+6.5% YoY

Equity

$64.63M

FY 2025 · Annual

-77.6% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents221.97M74.36M295.39M154.08M134.93M
Short-term Investments224.87M410.04M282.19M428.83M278.76M
Net Receivables429K4.06M1.23M13.87M70.29M
Inventory000366K32.75M
Other Current Assets265K117K63K(2.02M)1.22M
Total Current Assets448.4M489.79M580.88M603.06M528.08M
Property, Plant & Equipment (Net)1.26M1.06M1.5M2.02M1.52M
Goodwill00000
Intangible Assets00000
Long-term Investments05.47M29.83M119.52M0
Tax Assets00000
Other Non-current Assets0922K680K217K102K
Total Non-current Assets1.26M7.45M32M121.76M1.63M
Total Assets449.66M497.24M612.88M724.82M529.71M
Account Payables5.67M4.35M9.96M11.63M16.58M
Short-term Debt00012.12M0
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities6.23M6.55M35.92M15.75M103.06M
Total Current Liabilities20.68M29.07M58.1M103.55M120.12M
Long-term Debt19.9M00331.57M344.96M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities0000(1.05M)
Total Non-current Liabilities20.61M722K588K333.14M344.96M
Total Liabilities41.29M29.79M58.68M436.69M465.08M
Common Stock6K7K8K9K9K
Retained Earnings(543.7M)(693.04M)(902.4M)(1.22B)(1.51B)
Accumulated OCI45K(806K)218K163K452K
Other Stockholders Equity00000
Minority Interest00000
Total Equity408.37M467.45M554.2M288.12M64.63M
Total Debt20.97M1.16M1.64M345.74M346.48M
Net Debt(201M)(73.2M)(293.76M)191.66M211.55M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$130.9M
Short-term Investments$221.2M
Receivables$60.7M
Inventory$34.9M
Other Current$23.5M
Total Current Assets$471.2M
PP&E (Net)$1.4M
Long-term Investments$102.0K
Total Non-current Assets$1.5M
Total Assets$472.7M

Analysis

Selected assets total $472.7M for Latest. The largest visible component is Short-term Investments at $221.2M, about 46.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 12, 2026
3Initial statement of beneficial ownershipNov 12, 2026
SC 13GSC 13G filingNov 10, 2026
10-QQuarterly reportNov 2, 2026
8-KCurrent reportNov 2, 2026

How much cash does SNDX have?

Syndax Pharmaceuticals, Inc. (SNDX) reported $134.93M in cash and equivalents in fiscal 2025.

How much debt does SNDX carry?

Syndax Pharmaceuticals, Inc. (SNDX) reported $346.48M of total debt, with net debt of $211.55M.